Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bioadaptives (BDPT) Receivables - Other (2019 - 2025)

Bioadaptives' Receivables - Other history spans 4 years, with the latest figure at $2800.0 for Q3 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $2800.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2800.0, a N/A change, with the full-year FY2024 number at $2800.0, changed N/A from a year prior.
  • Receivables - Other hit $2800.0 in Q3 2025 for Bioadaptives, roughly flat from $2800.0 in the prior quarter.
  • Over the last five years, Receivables - Other for BDPT hit a ceiling of $2800.0 in Q4 2024 and a floor of $1623.0 in Q1 2021.
  • Historically, Receivables - Other has averaged $2295.6 across 3 years, with a median of $2800.0 in 2024.